Available
Specifications
Manufacturer: Eisai Co., Ltd.
Active ingredient:
Shelf life: 3 years (36 months) from the date of manufacture, subject to storage conditions.
Current price
$126
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
Store at a temperature not exceeding 25°C.
Protect from moisture and direct sunlight.
Store in the original packaging and out of reach of children.
Pariet is the trade name of a drug containing rabeprazole sodium, a proton pump inhibitor (PPI) used to reduce gastric acid secretion.
Indications for Use:
- Gastroesophageal Reflux Disease (GERD):
- Treatment of erosive or ulcerative forms.
- Maintenance therapy after healing.
- Peptic Ulcer Disease:
- Treatment of gastric and duodenal ulcers in the acute stage.
- Zollinger-Ellison Syndrome:
- Management of pathological hypersecretion conditions.
- Eradication of Helicobacter pylori:
- As part of combination therapy with antibacterial agents.
Contraindications:
- Known hypersensitivity to rabeprazole, substituted benzimidazoles, or any components of the drug.
- Pregnancy and Breastfeeding: Use is contraindicated.
- Pediatric Use: Not recommended for children under 12 years, as safety and efficacy have not been established.
Side Effects:
- Digestive System:
- Abdominal pain, diarrhea, nausea, vomiting.
- Flatulence, constipation, dry mouth.
- Nervous System:
- Headache, dizziness, insomnia, drowsiness.
- Allergic Reactions:
- Skin rash, pruritus (itching), urticaria (hives).
- Other:
- Asthenia (weakness), myalgia (muscle pain).
- Elevated liver enzyme levels.
Special Instructions:
- Exclusion of Gastric Malignancies:
- Before initiating therapy, ensure that malignant neoplasms of the stomach are ruled out, as treatment may mask symptoms and delay diagnosis.
- Severe Liver Failure:
- Use with caution. Regular monitoring of liver function is recommended.
- Long-Term Therapy:
- For prolonged use (more than one year), regular medical supervision is necessary.
- Drug Interactions:
- Rabeprazole may alter the absorption of medications whose bioavailability depends on gastric pH.
- Consultation Recommended:
- Before starting Pariet, consult a healthcare provider to determine the appropriateness of treatment and the optimal dosage. Self-medication is strongly discouraged and may lead to adverse outcomes.
- Enteric-coated tablets, 10 mg.
- Also available in 20 mg.
- The tablets have a protective coating that prevents the active substance from being destroyed in the acidic environment of the stomach.
